Rock Creek Pharmaceuticals, Inc. announced that the company has made a key independent appointment to the company's Board of Directors with the recent election of Dr. Sunitha Chundru Samuel as a new director. Dr. Samuel has been the Chief Executive Officer of Sierra Molecular Corporation, where Dr. Samuel also serves on its board of directors.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
2020 | Rock Creek Pharmaceuticals, Inc. Went Out of Business | CI |
2020 | Bankruptcy Judge Changed for Rock Creek Pharmaceuticals, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 17.04K | |
+42.57% | 739B | |
+32.34% | 598B | |
-6.03% | 353B | |
+17.28% | 318B | |
+3.40% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+5.89% | 164B |
- Stock Market
- Equities
- RCPIQ Stock
- News Rock Creek Pharmaceuticals, Inc.
- Rock Creek Pharmaceuticals, Inc. Appoints Sunitha Chundru Samuel as Director